HAYA Therapeutics has announced full enrolment and dosing of the first cohort in its Phase I clinical trial of HTX-001, a long non-coding ribonucleic acid (lncRNA)-targeting therapy developed for ...
Explore 25 Unsolved Scientific Mysteries that challenge everything you know. From dark matter to life's origins, these ...
American science is at a crossroads, but these extraordinary people, with their passion for knowledge and their dedication to our competitive future, are building its next chapter.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results